

GLP3 · 30 mg
Triple-agonist research peptide studied for GIP, GLP-1 and glucagon receptor activity in metabolic models.
Metabolic Research
Dual GIP/GLP-1 receptor research peptide in a 60 mg batch-coded vial, with its lot report published in full.
Lot analysis published for this batch. Independent Janoshik Analytical testing (Aug 2026) — purity, content and endotoxin, shown unedited further down this page.The 60 mg presentation of our dual-agonist research peptide, supplied lyophilised in a sealed, lot-coded vial. The Janoshik Analytical report for this lot is published unedited and can be verified independently.
Research use only. This product is supplied strictly for in-vitro laboratory research by qualified professionals. It is not a drug, food or cosmetic and must not be administered to humans or animals.
Published in full and unedited — verify it with the key printed on the report.


Triple-agonist research peptide studied for GIP, GLP-1 and glucagon receptor activity in metabolic models.


Dual GIP/GLP-1 receptor research peptide in a 30 mg batch-coded vial, with its lot report published in full.


Growth hormone-releasing factor analogue studied in metabolic and body-composition research models.
GLP2 60 mg
$110.00